Quick Answer: Japanese cosmetic ingredient requirements combine the Standards for Cosmetics with ingredient identity, purity, permitted use and Japanese consumer labelling. Screen the complete quantitative formula against Japanese prohibitions, restrictions and the specific rules for preservatives, ultraviolet absorbers and tar colours. Then reconcile the approved composition with the Japanese ingredient list and supporting safety records. A foreign listing or an INCI name alone does not establish permission to use an ingredient in Japan.
Define the product before checking the ingredients
Begin with the actual finished product: intended cosmetic function, application area, rinse-off or leave-on use, target users, directions and claims. Keep the formula revision and manufacturing site beside this description. A material can have a different regulatory outcome when the use changes, so the same ingredient list cannot be approved independently of the product brief.
This guide concerns ordinary cosmetics. A product presented through medicinal claims or a different regulated purpose may need another route, including consideration of the quasi-drug framework. Resolve classification with the Japanese responsible operator before assuming that an overseas cosmetic category carries over. Marketing descriptions, instructions and technical specifications should describe the same intended use.
Create a review worksheet with an owner for each unresolved question. Separate a missing supplier document from a confirmed legal restriction and a naming question from a safety question. This makes the eventual release decision traceable and prevents commercial urgency from converting an unanswered question into an assumed approval.
| Review area | Reference point | Working conclusion |
|---|---|---|
| Ordinary ingredient screening | Japanese Standards for Cosmetics | Check prohibitions and restricted uses |
| Preservatives and UV absorbers | Specific Japanese schedules and conditions | Confirm the exact entry and category |
| Tar colours | Japanese ministerial ordinance route | Check the permitted colour and use |
| Consumer ingredient names | Japanese full ingredient labelling rules | Approve the Japanese list for the actual pack |
Read the current Japanese standards and amendment trail
Use the MHLW consolidated Standards for Cosmetics as the core ingredient reference. Its Japanese text includes the July 2024 amendment in the restricted-ingredient schedule. The 12 July 2024 amendment notice explains the addition of cysteamine hydrochloride for a narrowly specified hair product use. This is a practical reminder that an ingredient decision must include its product category.
Do not treat an older English PDF as a complete current formula clearance. Preserve the Japanese text and relevant amendment information used for the review, record the access date and ask the local reviewer to check for subsequent notices before release. A translation is useful for collaboration, but the technical decision should be tied to the applicable Japanese wording.
Japanese schedule numbers are not interchangeable with EU or ASEAN annex numbers. Our ASEAN ingredient restrictions overview can help a team recognise regional review tasks, but its lists do not establish Japanese permission. Maintain a separate destination column and a separate conclusion for every market rather than copying the outcome from another jurisdiction.
Screen the complete composition and its actual function
Obtain a quantitative formula that resolves every supplied blend into its constituents. Record commercial raw-material names separately from chemical identity, INCI information, Japanese labelling names and concentration in the finished product. Include carriers, solvents and preservatives introduced through premixes so the reviewer can calculate total contributions.
The standards contain general prohibitions as well as the named prohibited and restricted schedules. Preservatives are addressed in Schedule 3, ultraviolet absorbers in Schedule 4, while tar colours follow the referenced ministerial ordinance. Confirm the actual function and applicable conditions rather than assuming every colourant or every substance associated with sun protection follows an identical positive-list route.
Where a schedule distinguishes product uses, document why the product fits the selected category. The 2024 cysteamine hydrochloride change concerns rinse-off hair-setting products used only on scalp hair; it is not a general permission for every hair or eye-area product. A vague supplier statement that an ingredient is allowed in Japan leaves this question unresolved.
Avoid building a universal concentration chart from memory. The assessment needs the exact entry, unit, category, restrictions and any linked conditions. Preserve the calculation for the final formula and obtain review of any ambiguous synonym or salt. The assessment should be reproducible by another reviewer without relying on the commercial name alone.
| Field | Useful evidence | Release question |
|---|---|---|
| Identity | Constituent composition and identifiers | Is the scheduled substance correctly matched? |
| Function | Purpose in the finished formula | Does a special list or use condition apply? |
| Amount | Finished formula and blend contributions | Are all relevant sources included? |
| Use category | Application area and directions | Does the permitted category match? |
| Decision | Reviewed entry and dated conclusion | Are open questions resolved? |
Review purity and raw-material quality beyond the ingredient name
The general provision of the standards addresses health hazards from raw materials, including impurities. An ingredient name on a permitted-use worksheet therefore does not settle raw-material quality. Establish specifications appropriate to the material and manufacturing process, and distinguish routine specification requirements from risk-based investigations.
Ask suppliers for meaningful identity and quality information: composition, source, manufacturing description where needed, specification, certificate of analysis and information on relevant impurities. For botanicals, record the plant and part, extraction or dilution system and constituent disclosure needed for the formula and label. For biological materials, establish whether additional source-related requirements need review.
The standards also contain a specific quality provision for glycerin concerning diethylene glycol. This illustrates why a finished-product ingredient screen must connect with raw-material purchasing and release. A supplier change can alter impurity risks even when the ingredient name and nominal formula percentage remain the same.
Build proportionate testing around the product and identified risks. Consider microbiological quality, preservation, stability and packaging compatibility where relevant. Testing is evidence for a defined formula and pack under defined conditions; it should not be presented as blanket proof of legal compliance or safety for all uses. Keep actual results distinct from supplier claims and draft protocols.
Translate the approved formula into a Japanese ingredient list
The Tokyo Metropolitan Institute of Public Health labelling guidance explains Japanese names, descending ingredient order, the ordering exception for ingredients at one percent or less and colourants, and the treatment of premixes. Review the complete joined label text against the final composition, including extracts, retained solvents and fragrance terminology.
Create a controlled mapping between each constituent and its Japanese display name. Resolve synonyms before artwork approval. A familiar English INCI list can support identity work but should not be pasted into Japanese artwork as if it completed the local naming requirement. Keep the source of each naming decision and have a competent Japanese reviewer check unfamiliar materials.
Do not confuse a carry-over labelling exception with permission to ignore an ingredient in the technical assessment. The reviewer still needs enough information to understand what is present, why it is present and whether it has an effect in the final product. A supplier confidentiality statement should lead to a secure disclosure arrangement, not an empty composition field.
Reconcile artwork at realistic print size, including the primary container and outer packaging arrangement. Check product identity, responsible operator details, batch coding and other applicable particulars alongside the ingredient list. Clear text and a documented final proof help prevent a correct technical formula from becoming a mislabelled commercial product.
| Stage | Controlled input | Output before the next step |
|---|---|---|
| 1. Formula review | Quantitative composition and use brief | Ingredient decisions and unresolved items |
| 2. Naming review | Approved constituents and Japanese name mapping | Complete joined ingredient list |
| 3. Artwork review | Final list, pack and consumer instructions | Approved readable production proof |
| 4. Batch release | Approved formula and material specifications | Reconciled manufacturing and quality record |
Check ingredient callouts and advertising separately
A complete ingredient list and a front-of-pack ingredient highlight serve different purposes. The MHLW notice dated 10 March 2025 updates the treatment of highlighting particular cosmetic ingredients. It explains the need to state the ingredient purpose and avoid a misleading impression of medicinal activity. Apply the review to packaging and advertising together.
Ask what a consumer will understand from the entire presentation: ingredient name, image, English wording, benefit statement and any nearby qualification. A small technical explanation cannot be assumed to correct a prominent medicinal impression. Support the stated purpose objectively and check it against the cosmetic positioning of the finished product.
Keep claim approval separate from formula approval in the project record. A lawful concentration does not prove a claimed consumer benefit, and a promising raw-material study may not establish the same effect for the finished product. Connect each significant claim with appropriate supporting evidence and the actual conditions of marketed use.
Assign responsibilities and control changes after approval
The manufacturer should provide accurate formula and site records, meaningful raw-material disclosures, quality information and notice of changes. The brand should maintain a consistent product brief and approve commercial claims and artwork. The Japanese responsible operator needs access to the information necessary for its local decisions and continuing obligations.
Agree the document handoff early with the OEM/ODM cosmetics manufacturer. Define which files are final, who can access confidential composition, how questions are answered and which conditions must be closed before production. A dossier index is useful only when the underlying evidence can actually be retrieved.
Our product information file planning guide illustrates useful record organisation for regional projects, while Japanese compliance decisions need their own local basis. Retain the Japanese assessment, the formula and artwork revisions, relevant source extracts, specifications, test reports and the signed release conclusion together.
Reassess changes to supplier, constituent composition, manufacturing process, intended use, claims or packaging. Document the affected batches and whether earlier testing still supports the changed product. For help organising a manufacturing evidence request, contact the project team with the product category, formula status and specific information gaps. Obtain a qualified Japanese review for the final market decision.
| Workstream | Manufacturer input | Brand and Japanese operator action |
|---|---|---|
| Composition | Complete constituents and revisions | Resolve Japanese ingredient assessment |
| Raw-material quality | Specifications and relevant results | Evaluate gaps and supplier changes |
| Japanese artwork | Formula and pack specifications | Approve names, particulars and claims |
| Continuing control | Advance change notice and batch support | Reassess local impact and retain decisions |
Frequently asked questions
Does an INCI name mean an ingredient is permitted in Japan?
No. INCI information supports identification. Japanese permission depends on the applicable standards, ingredient function, product category and conditions, while the consumer list needs appropriate Japanese names.
Can an ASEAN or EU compliant formula be transferred unchanged?
It requires a separate Japanese review. Foreign annex decisions and concentration limits do not replace Japanese schedules, use categories and labelling requirements.
Are all cosmetic ingredients on one Japanese positive list?
No. The framework combines general rules, prohibitions and restrictions with specific treatment of preservatives, ultraviolet absorbers and tar colours. Review the relevant route for each substance and purpose.
Can a premix be shown only by its trade name?
The technical reviewer needs its constituent composition. Japanese labelling guidance addresses the constituent ingredients of premixes; approve the final display names and list against the actual formula.
What should trigger another ingredient review?
Changes in constituent composition, suppliers, use area, directions, claims, process or packaging can affect the assessment. Review the impact before implementing the change and record the decision.
Last reviewed: 25 October 2026. General technical planning information only, not product-specific legal or safety advice. Confirm current Japanese requirements with a qualified local reviewer before manufacture, import or sale.